Abstract:Background: Much research supports the emerging theory that Alzheimer's disease originates from a pathological cerebral metabolic disturbance in glucose metabolism, analogous to insulin resistance in type 2 diabetes. This has led to the theory that ketone bodies may provide an alternative neuronal fuel, correcting, in part, the neuronal energy deficiency and improving cognition in Alzheimer's disease. Aims: To evaluate the literature of human studies on the effectiveness of improving cognition in Alzheimer's disease through a low-carbohydrate diet or administration of exogenous ketones. Methods: A literature review was conducted, with the PRISMA guidelines used to guide this review. The PICO (Population, Intervention, Comparison, Outcome) concept tool was used to search for terms generated through background research. Full-text, peer-reviewed English articles from SocINDEX, Medline, CINAHL, PsychInfo and ScienceDirect were selected, using exclusion and inclusion criteria. Six human studies in which cognition was assessed following a low-carbohydrate diet or administration of exogenous ketones were evaluated. Findings: Some cognitive improvements were demonstrated in all studies in participants with mild-moderate Alzheimer's disease, but not in all cognitive tests and not at all time points. Cognitive improvements returned to baseline after the intervention. Two studies included genetic data and found that cognitive improvement was most notable in those without an E4 allele. Conclusions: This review provides some preliminary support for the potential therapeutic use of ketones in Alzheimer's disease. However, considerable future research is needed, as this is a relatively novel research area. The findings support the suggestion of a gene-environment interaction in the aetiology of Alzheimer's disease, and may contribute to an understanding of how the E4 allele is linked to the pathology of Alzheimer's disease. This review provides suggestions for improving screening for Alzheimer's disease from a nursing perspective—for example, by screening for risk factors, such as hyperinsulinemia and reduced cerebral metabolic rate of glucose.

The cerebral hypometabolism model of Alzheimer's disease explored: can a ketogenic diet improve cognition in Alzheimer's disease? A review of the literature